Drug Type Biological products |
Synonyms |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Focal cortical dysplasia | Phase 2 | South Korea | - | |
PIK3CA-related overgrowth syndrome | Phase 2 | South Korea | - | |
Tuberous Sclerosis | Phase 2 | South Korea | - |